⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103743 | 0.88 | MAPT (0.42) | — | |
| SCHEMBL104221 | 0.83 | — | — | |
| SCHEMBL3357269 | 0.81 | CRBN (0.39) | — | |
| SCHEMBL3813285 | 0.75 | MEN1 (0.34) | — | |
| SCHEMBL7469992 | 0.74 | DRD2 (0.41) | — | |
| SCHEMBL3352434 | 0.72 | MEN1 (0.46) | — | |
| SCHEMBL393532 | 0.72 | PARP10 (0.56) | — | |
| SCHEMBL18584725 | 0.71 | HTR2C (0.52) | — | |
| SCHEMBL19639065 | 0.71 | CRBN (0.41) | — | |
| SCHEMBL29051757 | 0.71 | MTNR1A (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2260 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11987588-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2024-05-21 | — | — | US | claimed |
| US-11952376-B2 | Substituted amino acids as integrin inhibitors | PLIANT THERAPEUTICS, INC. (US) | 2024-04-09 | — | — | US | claimed |
| CN-116568677-A | piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the treatment of MTAP deficiency and/or MTA accumulating cancers | 探戈医药股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| EP-4188920-A1 | PIPERIDIN-1-YL-N-PYRYDINE-3-YL-2-OXOACETAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF MTAP-DEFICIENT AND/OR MTA-ACCUMULATING CANCERS | Tango Therapeutics, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| EP-3720858-B1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2023-06-07 | — | — | EP | claimed |
| US-20220396579-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2022-12-15 | — | — | US | claimed |
| WO-2022026892-A1 | PIPERIDIN-1- YL-N-PYRYDI NE-3-YL-2-OXOACET AM IDE DERIVATIVES USEFUL FOR THE TREATMENT OF MTAP-DEFICIENT AND/OR MT A-ACCUMULATING CANCERS | TANGO THERAPEUTICS, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| US-20210032242-A1 | AROMATIC HETEROCYCLIC SUBSTITUTED OLEFIN COMPOUND, PREPARATION METHOD FOR SAME, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF | SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) | 2021-02-04 | — | — | US | claimed |
| US-20200385395-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2020-12-10 | — | — | US | claimed |
| EP-3720858-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2020-10-14 | — | — | EP | claimed |
| EP-0484437-A4 | RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION | SEARLE & CO (US) | 1994-06-01 | — | — | EP | claimed |
| EP-0218548-B1 | CHROMOGENE QUINAZOLINE DERIVATIVES | CIBA-GEIGY AG (CH) | 1993-08-11 | — | — | EP | claimed |
| EP-0484437-A1 | RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION | G.D. Searle & Co. (US) | 1992-05-13 | — | — | EP | claimed |
| WO-1992001667-A1 | RENAL-SELECTIVE PRODRUGS FOR CONTROL OF RENAL SYMPATHETIC NERVE ACTIVITY IN THE TREATMENT OF HYPERTENSION | G.D. SEARLE & CO. (US) | 1992-02-06 | — | — | WO | claimed |
| WO-1991001724-A1 | RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION | G.D. SEARLE & CO. (US) | 1991-02-21 | — | — | WO | claimed |
| EP-0159295-B1 | CHROMOGENE BIS-QUINAZOLINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS A DYE PRECURSOR IN PRESSURE-SENSITIVE OR HEAT-SENSITIVE REGISTRATION MATERIALS | CIBA-GEIGY AG (CH) | 1989-03-15 | — | — | EP | claimed |
| US-4766211-A | FOR PRESSURE SENSITIVE OR HEAT SENSITIVE RECORDING MATERIALS; LIGHTFASTNESS | CIBA-GEIGY CORPORATION (US) | 1988-08-23 | — | — | US | claimed |
| EP-0135469-B1 | CHROMOGENIC QUINAZOLINE COMPOUNDS | CIBA-GEIGY AG (CH) | 1987-06-16 | — | — | EP | claimed |
| EP-0109930-B1 | CHROMOGENIC BIS-QUINAZOLINE COMPOUNDS, METHOD OF PREPARING THEM AND THEIR USE AS CHROMOGENES IN PRESSURE-SENSITIVE OR HEAT-SENSITIVE RECORDING MATERIALS | CIBA-GEIGY AG (CH) | 1986-09-17 | — | — | EP | claimed |
| US-4555569-A | PRESSURE AND HEAT SENSITIVE ELEMENTS | CIBA-GEIGY CORPORATION (US) | 1985-11-26 | — | — | US | claimed |